4//SEC Filing
Pennington James 4
Accession 0001415889-18-001136
CIK 0001604191other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 1:20 PM ET
Size
15.5 KB
Accession
0001415889-18-001136
Insider Transaction Report
Form 4
Pennington James
CHIEF MEDICAL OFFICER
Transactions
- Award
Options
2018-07-12+75,000→ 75,000 totalExercise: $3.04Exp: 2023-06-28→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Options with respect to 37,500 shares vest upon the acceptance of a U.S. IND for MS 1819, and the remaining 37,500 shares vest upon the the first CF patient dosed with MS1819 anywhere in the globe.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001668704
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 1:20 PM ET
- Size
- 15.5 KB